Dr. Stefan Oschmann
Dr. Stefan Oschmann has been Chairman of the Executive Board and CEO of Merck since May 2016. Previously, Stefan Oschmann served as the Vice-Chairman and Deputy CEO. In this role he was responsible for strategy development of the Merck Group. He joined Merck in 2011 as CEO of the Biopharma division and member of the Executive Board. From 2013 to 2014 he was responsible for the healthcare business sector of Merck. In that role he oversaw the Biopharma, Consumer Health, Allergopharma, and Biosimilars businesses. Before joining Merck, he worked for the US pharma company MSD, where he served as President of Emerging Markets.
Other positions included member of senior management and corporate officer with responsibility for the business in Europe, the Middle East, Africa, and Canada; Senior Vice-President in charge of Worldwide Human Health Marketing as well as Vice-President of Europe and the German business.
He started his career at the International Atomic Energy Agency (IAEA) in 1985, before moving to the German Animal Health Federation (BfT), a member association of the German Chemical Industry Association (VCI), in 1987. He studied veterinary medicine at Ludwig-Maximilian University, Munich from 1977 to 1982 and earned a doctorate there in 1985.